The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
But essentially the Gabonese have been using this for a long time and it's a kind of an atypical psychedelic. It's not a psychedelic that we normally think about with psilocybin and LSD where there are visual perceptual changes, right?
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
sort of if you have sort of psilocybin lsd here you've got mdma here more of an in pathogen and then you have ketamine as more of a dissociative and then these really atypical ones like ibogaine which we've already talked about